3D Cell Culture Market Size Anticipated To Reach $1.69 Billion By 2024
“North America dominated the next generation sequencing data analysis market with a share of over 40% as a result of the presence of several organizations operating in this region.�
Global 3D Cell Culture Market is anticipated to reach USD 1.69 billion by 2024, according to a new report by Grand View Research, Inc. Potential of this technology to replace and reduce the usage of animal models for histological analysis and biochemical assays is expected to fuel demand for 3D cell culture products thus driving growth in the coming years. Access Full Research Report on 3D Cell Culture Market: http://www.grandviewresearch.com/industry-analysis/3d-cell-culture-market Advent of technology with respect to spheroid formation and matured assay methods, is expected to boost the emergence of 3D optimized assays, kits, and protocols, in turn, expediting the entire research process. In addition, the scope of threedimensional (3D) cell culturing experiments for evaluation of drug moiety is anticipated to grow owing to advantages associated with its usage. These advantages include increased cell to extra cellular matrix (ECM) as well as intercellular interactions,
Follow Us:
variation in the proliferation zones, ease for analysing impact of site-specific stromal tissue components in the tumor microenvironment. Research initiatives carried out to develop multidimensional cultures that offer compatibility with automated lab equipment and suitability for HTS feature in order to facilitate high content screening assay, signalling, and migration are expected to fuel the growth of this vertical through to 2024. Further key findings from the report suggest:
Scaffold-based technique accounted for the revenue share of over 40% because of the potential these possess for the recreation of structural and physical environment of a living tissue. Availability of choice for the material and structure of the scaffold for different in vitro applications is supportive for the estimated revenue share of this segment. Hydrogel or ECM and solid scaffolds are estimated to capture a comparatively sizable share of the revenue, attributed to the presence of different products in this segment.
Spheroid development techniques are estimated to contribute significantly in increasing the revenue share of scaffold-free technology. These enable multicellular arrangement, thus making them an influential tool for a range of applications, particularly in cancer and stem cell research. Oncology is estimated to account for the dominant share in 2015 owing to the presence of higher incidence rate of cancers coupled with phenotypic heterogeneity achieved using 3D culturing. Stem cell research is anticipated to witness lucrative growth in the coming years as a consequence of the upcoming projects in this segment for development of effective therapies.
Key end users for this technology are pharma & biotech entities, research laboratories and institutes. Pharma & biotech entities accounted for the largest share of the revenue in 2015 owing to the high usage of technology in different steps of drug discovery which include target validation, lead optimization, penetration studies, and safety assessment or toxicity screening.
North America dominated the next generation sequencing data analysis market with a share of over 40% as a result of the presence of several organizations operating in this region. Moreover, the significant number of R&D projects carried
Follow Us:
out in institutes is resulting in the high demand, affecting the revenue growth significantly.
However, Asia Pacific is expected to witness substantially high growth through to 2024, which is attributable to the rise in number of research grants for drug development and tissue engineering projects in the developing economies of this region. Furthermore, positive R&D outcomes encouraging the incorporation of three dimensional cultures in regenerative medicine is expected to impact this sector with potential opportunities for growth.
The market is fragmented in nature and includes established as well as emerging players These entities include 3D Biomatrix, Corning Inc, Nano3D Biosciences, Merck, Becton Dickinson and Company, Thermo Fisher Scientific, InSphero AG, Lonza Group, Tecan, 3D Biotek LLC, VWR International, LLC, and Global Cell Solutions, Inc.
These companies are involved in collaborations and co-marketing agreements for enhancement of product portfolio as well as global presence. For instance, Tecan and Cell Spring entered into collaboration for automation of the 3D Bloom platform on a Freedom EVO workstation.
Read Our Blogs from Same Category By Grand View Research: http://www.grandviewresearch.com/blogs/healthcare Table of Content of 3D Cell Culture Market Research Report: Chapter 1 Research Methodology 1.1 Information procurement 1.2 Data Analysis Chapter 2 Executive Summary Chapter 3 Market Snapshot Chapter 4 Market Variables, Trends & Scope 4.1 Market segmentation & scope 4.1.1 Market Driver Analysis
Follow Us:
4.1.1.1 Rising demand for organ transplantation & tissue engineering 4.1.1.2 Technological advancements in scaffold free technology 4.1.1.3 Rising investment and R & D funding for cell based research 4.1.2 Market Restraint Analysis 4.1.2.1 High cost associated with implementation 4.1.2.2 Lack of compatibility and consistency 4.2 Penetration & growth prospect mapping for technology, 2015 4.3 3D cell culture - SWOT Analysis, By Factor (political & legal, economic and technological) 4.4 Industry Analysis - Porter’s Chapter 5 Market Categorization 1: Technology Estimates & Trend Analysis 5.1 3D cell culture market: Technology movement analysis 5.2 Scaffold based 5.2.1 Global scaffold based 3D cell culture market, 2013 - 2024 (USD Million) 5.2.2 Hydrogels 5.2.2.1 Global hydrogels market, 2013 - 2024 (USD Million) 5.2.3 Polymeric scaffolds 5.2.3.1 Global polymeric scaffolds market, 2013 - 2024 (USD Million) 5.2.4 Micropatterned microplates 5.2.4.1 Global micropatterned microplates market, 2013 - 2024 (USD Million) 5.3 Scaffold free 5.3.1 Global scaffold free 3D cell culture market, 2013 - 2024 (USD Million) 5.3.2 Hanging drop microplates 5.3.2.1 Global hanging drop microplates market, 2013 - 2024 (USD
Follow Us:
Million) 5.3.3 Spheroid microplates with ULA coating 5.3.3.1 Global spheroid microplates with ULA coating market, 2013 2024 (USD Million) 5.3.4 Microfluidic 3D cell culture 5.3.4.1 Global microfluidic 3D cell culture market, 2013 - 2024 (USD Million) 5.3.5 Magnetic levitations & 3D bioprinting 5.3.5.1 Global magnetic levitations & 3D bioprinting market, 2013 2024 (USD Million) 5.4 Bioreactors 5.4.1 Global bioreactors market, 2013 - 2024 (USD Million) Chapter 6 Market Categorization 2: Application Estimates & Trend Analysis 6.1 3D cell culture market: Application movement analysis 6.2 Cancer 6.2.1 Global cancer market, 2013 - 2024 (USD Million) 6.3 Tissue engineering & Immunohistochemistry 6.3.1 Global tissue engineering & immunohistochemistry market, 2013 2024 (USD Million) 6.4 Drug development 6.4.1 Global drug development market, 2013 - 2024 (USD Million) 6.5 Stem cell research 6.5.1 Global stem cell research market, 2013 - 2024 (USD Million) 6.6 Others 6.6.1 Global other applications market, 2013 - 2024 (USD Million) Chapter 7 Market Categorization 3: End Use Estimates & Trend Analysis 7.1 3D cell culture market: End use movement analysis
Follow Us:
7.2 Biotechnology and pharmaceutical organizations 7.2.1 Global biotechnology and pharmaceutical organizations market, 2013 - 2024 (USD Million) 7.3 Research laboratories and institutes 7.3.1 Global research laboratories and institutes market, 2013 - 2024 (USD Million) 7.4 Hospitals and diagnostic centers 7.4.1 Global hospitals and diagnostic centers market, 2013 - 2024 (USD Million) 7.5 Others 7.5.1 Global other end users market, 2013 - 2024 (USD Million) Chapter 8 Market Categorization 4: Regional Estimates & Trend Analysis, by Product, Application, & End - use 8.1 3D cell culture market share by region, 2015 & 2024 8.2 North America 8.2.1 North America 3D cell culture market, 2013 - 2024 (USD Million) 8.2.2 U.S. 8.2.2.1 U.S. 3D cell culture market, 2013 - 2024 (USD Million) 8.2.3 Canada. 8.2.3.1 Canada 3D cell culture market, 2013 - 2024 (USD Million) 8.3 Europe 8.3.1 Europe 3D cell culture market, 2013 - 2024 (USD Million) 8.3.2 Germany. 8.3.2.1 Germany 3D cell culture market, 2013 - 2024 (USD Million) 8.3.3 UK. 8.3.3.1 UK 3D cell culture market, 2013 - 2024 (USD Million) 8.4 Asia Pacific.
Follow Us:
8.4.1 Asia Pacific 3D cell culture market, 2013 - 2024 (USD Million) 8.4.2 Japan. 8.4.2.1 Japan 3D cell culture market, 2013 - 2024 (USD Million) 8.4.3 China. 8.4.3.1 China 3D cell culture market, 2013 - 2024 (USD Million) 8.5 Latin America. 8.5.1 Latin America 3D cell culture market, 2013 - 2024 (USD Million) 8.5.2 Brazil 8.5.2.1 Brazil 3D cell culture market, 2013 - 2024 (USD Million) 8.6 Middle East & Africa. 8.6.1 Middle East & Africa 3D cell culture market, 2013 - 2024 (USD Million) 8.6.2 South Africa 8.6.2.1 South Africa 3D cell culture market, 2013 - 2024 (USD Million) Chapter 9 Competitive Landscape 9.1 Strategy framework 9.2 Market participation categorization 9.2.1 Merck 9.2.1.1 Company overview 9.2.1.2 Financial performance 9.2.1.3 Product benchmarking 9.2.1.4 Strategic initiatives 9.2.2 Thermo Fisher Scientific, Inc. 9.2.2.1 Company overview 9.2.2.2 Financial performance 9.2.2.3 Product benchmarking 9.2.2.4 Strategic initiatives
Follow Us:
9.2.3 Becton, Dickinson and Company 9.2.3.1 Company overview 9.2.3.2 Financial performance 9.2.3.3 Product benchmarking 9.2.3.4 Strategic initiatives 9.2.4 Nano 3D Biosciences 9.2.4.1 Company overview 9.2.4.1 Financial Performance 9.2.4.2 Product benchmarking 9.2.4.3 Strategic initiatives 9.2.5 Promocell GmbH 9.2.5.1 Company overview 9.2.5.2 Financial performance 9.2.5.3 Product benchmarking 9.2.5.4 Strategic initiatives 9.2.6 Corning Inc. 9.2.6.1 Company overview 9.2.6.2 Financial performance 9.2.6.3 Product benchmarking 9.2.6.4 Strategic initiatives 9.2.7 3D Biomatrix 9.2.7.1 Company overview 9.2.7.2 Financial performance 9.2.7.3 Product benchmarking 9.2.7.4 Strategic initiatives 9.2.8 Lonza 9.2.8.1 Company overview
Follow Us:
9.2.8.2 Financial performance 9.2.8.3 Product benchmarking 9.2.8.4 Strategic initiatives 9.2.9 VWR International, LLC 9.2.9.1 Company overview 9.2.9.2 Financial performance 9.2.9.3 Product benchmarking 9.2.9.4 Strategic initiatives 9.2.10 Tecan Trading AG. 9.2.10.1 Company overview 9.2.10.2 Financial performance 9.2.10.3 Product benchmarking 9.2.10.4 Strategic initiatives 9.2.11 3D Biotek LLC. 9.2.11.1 Company overview 9.2.11.2 Financial performance 9.2.11.3 Product benchmarking 9.2.11.4 Strategic initiatives 9.2.12 Global Cell Solutions, Inc. 9.2.12.1 Company overview 9.2.12.2 Financial performance 9.2.12.3 Product benchmarking 9.2.12.4 Strategic initiatives 9.2.13 InSphero AG 9.2.13.1 Company overview 9.2.13.2 Financial performance
Follow Us:
9.2.13.3 Product benchmarking 9.2.13.4 Strategic initiatives About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com Web – http://www.grandviewresearch.com/
Follow Us: